TITLE

Drops decrease tear evaporation

AUTHOR(S)
McCulley, James P.
PUB. DATE
April 2011
SOURCE
Ophthalmology Times;4/1/2011, Vol. 36 Issue 7, p30
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article focuses on the study of using artificial tears to treat dry eye in San Diego, California. It says that artificial tear products containing propylene glycol reduces evaporation of tears in patients with aqueous-deficient dry eye associated with meibomian gland dysfunction (MGD). Dr. James P. McCulley, chairman of the Department of Ophthalmology at University of Texas Southwestern Medical Center, mentions the recommended dose for the application of the artificial tears.
ACCESSION #
60170010

 

Related Articles

  • Oral supplement relieves symptoms. McCulley, James P. // Ophthalmology Times;4/1/2011, Vol. 36 Issue 7, p24 

    The article focuses on the study on the use of omega-3 fatty acid oral supplement to treat dry eye in Dallas Texas. It says patients with aqueous-deficient dry eye with or without meibomian gland disease are enrolled in the study. According to James P. McCulley, chairman of the Department of...

  • Oral supplement relieves symptoms. Krader, Cheryle Guttman; McCulley, James P. // Optometry Times;May2011, Vol. 3 Issue 5, p22 

    The article discusses the study that proves the efficacy of TheraTears Nutrition from Advanced Vision Research in the management of dry eye disease (DED). James P. McCulley, MD of the Department of Ophthalmology at the University of Texas Southwestern Medical Center shares on the clinical trial...

  • New dry eye therapy shows good results in phase 2 study.  // Primary Care Optometry News;Jun2011, Vol. 16 Issue 6, p19 

    The article reports on a study which found that a new dry eye therapy involving the investigational molecule SAR 1118 reduced corneal staining, increased tear production and improved ocular surface disease index quality of life scores.

  • Low-viscosity artificial tear targets mild dry eye. Nemec, John // Ophthalmology Times;6/1/2002, Vol. 27 Issue 11, p62 

    Presents information on the GenTeal Mild lubricant drops which provide artificial tears for patients suffering from mild symptoms of dry eye. Primary advantage of the product; Importance of the transient preservative; Risk for long-term dry eye.

  • Artificial tears shown to improve patients' dry eye, visual symptoms. Hemphill, Nancy // Primary Care Optometry News;Mar2009, Vol. 14 Issue 3, p6 

    The article reports on several studies which found that treatment with artificial tears can improve the symptoms of discomfort as well as visual symptoms among dry eye patients.

  • Cyclosporine mitigates dry eye symptoms over 2 years. Hasson, Matt // Ocular Surgery News Asia-Pacific;Apr2010, Vol. 21 Issue 4, p8 

    The article reports that switching from the use of topical cyclosporine to artificial tears can result in worse dry eye conditions. According to a study, patients who maintained cyclosporine treatment for a two-year period were found to have improvements in their dry eye symptoms. Cyclosporine...

  • CMC tear garners patient preference. Guttman, Cheryl; Hom, Milton M. // Ophthalmology Times;8/15/2006, Vol. 31 Issue 16, p41 

    The article discusses a comparison study in the United States to determine whether dry eye-afflicted patients prefer a carboxymethylcellulose (CMC)-based artificial tear product over one formulated with propylene glycol, polyethylene glycol, and hydroxypropyl guar. According to the study,...

  • hypromellose.  // Royal Society of Medicine: Medicines;2002, p293 

    The article presents information on hypromellose. It is a constituent of artificial tears, which are used to treat extremely dry eyes due to certain disorders. It is available as eye-drops and often in combination with a variety of drugs. It is regarded as safe in normal topical use.

  • Working to complete the dry eye therapeutic story. Ouster III, George W. // Ophthalmology Times;5/1/2013, Vol. 38 Issue 9, p17 

    The article discusses new treatments for dry eye disease being powered by enhanced knowledge and technological advances. It describes the Controlled Adverse Environment (CAE) model's utility in screening patients with dry eye and the use of the Ocular Protection Index (OPI) as a ratio of the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics